InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Nally Michael. Director active across 1 company, notably Generate Biomedicines, Inc.. Aggregated, 2 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €207k. History available since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations